正海生物
(300653)
| 流通市值：39.98亿 | | | 总市值：39.98亿 |
| 流通股本：1.80亿 | | | 总股本：1.80亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 76,575,880.12 | 134,717,712.56 | 107,764,512.99 | 200,356,949.21 |
| 应收票据及应收账款 | 51,877,514.43 | 51,814,240.39 | 52,780,919.26 | 46,064,069.79 |
| 其中：应收票据 | 762,854.4 | - | - | - |
| 应收账款 | 51,114,660.03 | 51,814,240.39 | 52,780,919.26 | 46,064,069.79 |
| 应收款项融资 | 1,720,410.49 | 1,988,684.09 | 1,025,539.08 | 1,029,782.4 |
| 预付款项 | 3,335,596.08 | 7,642,455.03 | 10,290,427.31 | 5,178,421.35 |
| 其他应收款合计 | 1,162,961.49 | 1,669,240.49 | 2,351,787.9 | 1,962,229.9 |
| 存货 | 36,717,909.37 | 38,934,517.16 | 37,138,273.1 | 35,654,177.06 |
| 其他流动资产 | 631,835.14 | 430,651.33 | 224,900.44 | 1,661,907.36 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 770,633,742.64 | 721,786,720.43 | 690,251,925.02 | 747,503,222.35 |
| 非流动资产: | | | | |
| 投资性房地产 | 88,706.04 | 96,167.37 | 103,628.7 | 111,090.03 |
| 固定资产 | 235,340,967.4 | 217,742,265.94 | 220,905,952.81 | 223,077,762.64 |
| 在建工程 | 8,086,746.62 | 4,575,304.29 | 2,962,068.21 | 3,149,800.6 |
| 无形资产 | 35,011,545.41 | 35,747,353.65 | 36,442,656.84 | 36,796,131.22 |
| 长期待摊费用 | 257,778.17 | 365,584.31 | 473,390.45 | 505,696.58 |
| 递延所得税资产 | 2,782,658.41 | 2,428,508.14 | 2,623,212.58 | 2,646,980.29 |
| 其他非流动资产 | 1,622,483.98 | 6,466,854.93 | 1,100,401.42 | 6,119,206.06 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 283,190,886.03 | 267,422,038.63 | 264,611,311.01 | 272,406,667.42 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,053,824,628.67 | 989,208,759.06 | 954,863,236.03 | 1,019,909,889.77 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 39,112,213.11 | 21,322,692.63 | 31,990,005.9 | 36,450,808.08 |
| 其中：应付票据 | 18,009,112.22 | 14,957,377.45 | 6,131,411.87 | 9,120,543.34 |
| 应付账款 | 21,103,100.89 | 6,365,315.18 | 25,858,594.03 | 27,330,264.74 |
| 合同负债 | 12,845,067.24 | 1,691,648 | 1,642,342.64 | 6,433,698.22 |
| 应付职工薪酬 | 14,274,506.66 | 23,463,526.65 | 14,459,516.29 | 14,028,558.48 |
| 应交税费 | 8,137,103.75 | 6,762,680.23 | 8,463,479.23 | 15,359,578.95 |
| 其他应付款合计 | 15,172,642.83 | 14,745,541.47 | 15,425,515.45 | 13,066,696.23 |
| 其他流动负债 | 461,416.08 | 52,319.01 | 34,125.87 | 22,498.8 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 90,002,949.67 | 68,038,407.99 | 72,014,985.38 | 85,361,838.76 |
| 非流动负债: | | | | |
| 递延收益 | 9,124,493.28 | 9,504,233.75 | 9,675,545.85 | 9,818,331.6 |
| 递延所得税负债 | 6,631,820.62 | 6,223,104.43 | 6,223,104.43 | 6,223,104.43 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 15,756,313.9 | 15,727,338.18 | 15,898,650.28 | 16,041,436.03 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 105,759,263.57 | 83,765,746.17 | 87,913,635.66 | 101,403,274.79 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 180,000,000 | 180,000,000 | 180,000,000 | 180,000,000 |
| 资本公积 | 169,418,284.73 | 169,418,284.73 | 169,418,284.73 | 169,418,284.73 |
| 盈余公积 | 99,202,234.55 | 80,100,905.37 | 80,100,905.37 | 80,100,905.37 |
| 未分配利润 | 499,444,845.82 | 475,923,822.79 | 437,430,410.27 | 488,987,424.88 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 948,065,365.1 | 905,443,012.89 | 866,949,600.37 | 918,506,614.98 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 948,065,365.1 | 905,443,012.89 | 866,949,600.37 | 918,506,614.98 |
| 负债和股东权益合计 | 1,053,824,628.67 | 989,208,759.06 | 954,863,236.03 | 1,019,909,889.77 |
| 公告日期 | 2024-04-02 | 2023-10-24 | 2023-08-01 | 2023-04-25 |
| 审计意见(境内) | 标准无保留意见 | | | |